» Articles » PMID: 9512138

Quality of Life in Persons with Irritable Bowel Syndrome: Development and Validation of a New Measure

Overview
Journal Dig Dis Sci
Specialty Gastroenterology
Date 1998 Mar 25
PMID 9512138
Citations 286
Authors
Affiliations
Soon will be listed here.
Abstract

How irritable bowel syndrome (IBS) and its treatment affect quality of life (QOL) is important. To develop a quality-of-life measure specific to irritable bowel syndrome, items were generated using a conceptual model and qualitative interviews with persons diagnosed using the Rome criteria. Symptom frequency and bothersomeness indices were created. Psychometric evaluation methods involved an initial cross-sectional survey followed by a repeat survey. The resulting 34-item measure demonstrated high internal consistency (Cronbach's alpha = 0.95) and high reproducibility (ICC = 0.86) with average time of seven days (SD = 1). For discriminant validity: number of symptoms (P < 0.05), self-reported severity of symptoms (P < 0.001), and the functional bowel disorder severity index (P < 0.001) significantly predicted IBS-QOL scores. Convergent validity and analyses confirmed predictions that scores are more closely related to psychological well-being (0.45) than to function (0.36). We conclude this measure meets established psychometric criteria for reliability and validity; testing of its responsiveness is warranted.

Citing Articles

Comparison of Rifaximin Monotherapy and Rifaximin Combined with Probiotics in Patients with Irritable Bowel Syndrome: A Randomized Controlled Trial.

Oh C, Chung H, Kim Y, Kim J Nutrients. 2025; 17(5).

PMID: 40077633 PMC: 11901931. DOI: 10.3390/nu17050763.


The effect of acupuncture on quality of life in patients with irritable bowel syndrome: A systematic review and meta-analysis.

Zhou J, Lamichhane N, Xu Z, Wang J, Quynh V, Huang J PLoS One. 2025; 20(2):e0314678.

PMID: 39946356 PMC: 11824959. DOI: 10.1371/journal.pone.0314678.


Reproductive and sexual health concerns in gastrointestinal illness: a narrative review.

Hacker K, Bedell A Transl Gastroenterol Hepatol. 2025; 10:15.

PMID: 39944576 PMC: 11811567. DOI: 10.21037/tgh-24-38.


Real-world safety of linaclotide in Chinese patients with irritable bowel syndrome with constipation: a multicenter, single-arm, prospective observational study.

Xiao Y, Meng X, Luo Q, Hou X, Jin J, Zhong X Therap Adv Gastroenterol. 2025; 18:17562848251314819.

PMID: 39917729 PMC: 11800259. DOI: 10.1177/17562848251314819.


The Effects of Digital eHealth Versus Onsite 2-Day Group-Based Education in 255 Patients With Irritable Bowel Syndrome: Cohort Study.

Berentsen B, Thuen C, Hillestad E, Steinsvik E, Hausken T, Hatlebakk J JMIR Hum Factors. 2025; 12:e43618.

PMID: 39899743 PMC: 11809937. DOI: 10.2196/43618.


References
1.
Guyatt G, Feeny D, Patrick D . Measuring health-related quality of life. Ann Intern Med. 1993; 118(8):622-9. DOI: 10.7326/0003-4819-118-8-199304150-00009. View

2.
Dancey C, Backhouse S . Towards a better understanding of patients with irritable bowel syndrome. J Adv Nurs. 1993; 18(9):1443-50. DOI: 10.1046/j.1365-2648.1993.18091443.x. View

3.
Wild D, Patrick D, Johnson E, BERZON R, Wald A . Measuring health-related quality of life in persons with genital herpes. Qual Life Res. 1995; 4(6):532-9. DOI: 10.1007/BF00634748. View

4.
Eypasch E, Wood-Dauphinee S, Williams J, Ure B, Neugebauer E, Troidl H . [The Gastrointestinal Quality of Life Index. A clinical index for measuring patient status in gastroenterologic surgery]. Chirurg. 1993; 64(4):264-74. View

5.
Drossman D, Li Z, Toner B, Diamant N, Creed F, Thompson D . Functional bowel disorders. A multicenter comparison of health status and development of illness severity index. Dig Dis Sci. 1995; 40(5):986-95. DOI: 10.1007/BF02064187. View